AKT_Prostate_RAD001_v_PLACEBO

GSE1413

Mus musculus

38 Downloadable Samples

Affymetrix Mouse Expression 430A Array (moe430a)

Submitter Supplied Information

Description

Transgenic (Probasin driven Myr-AKT)or wild-type littermates were treated with RAD001 or placebo and sacrificed at 12 and 48 hours following the beginning of treatment

PubMed ID

15156201

Publication Title

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.

Total Samples

Submitter’s Institution

Duke Institute for Genome Sciences and Policy

Authors

Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, Loda M, Lane HA, Sellers WR

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-1413

No rows found